Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma is a research paper published in Pharmaceuticals (2022). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute, National Institutes of Health
Grant: CA072851
National Cancer Institute, National Institutes of Health
Grant: CA184792
National Cancer Institute, National Institutes of Health
Grant: CA187956
National Cancer Institute, National Institutes of Health
Grant: CA202797
National Cancer Institute, National Institutes of Health
Grant: CA227602
NCI NIH HHS
Grant: R01 CA184792
NCI NIH HHS
Grant: R01 CA227602
NCI NIH HHS
Grant: R01 CA072851
NIH HHS
Grant: CA184792, CA187956, CA227602, CA072851, and CA202797
NCI NIH HHS
Grant: U01 CA187956
NCI NIH HHS
Grant: R01 CA202797
National Institutes of Health
Grant: 5R01CA202797-02
MicroRNA Biomarkers for Determining Treatment Response in Colorectal Cancer
National Institutes of Health
Grant: 7R01CA184792-05
Development of microRNA Biomarkers For Noninvasive Detection of Colorectal Cancer
National Institutes of Health
Grant: 2R01CA072851-04
BIOLOGY AND DIAGNOSIS OF HNPCC
National Institutes of Health
Grant: 1U01CA187956-01
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data
National Institutes of Health
Grant: 5R01CA227602-04
Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer
FWCI
4.06
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals